• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缓解溃疡性结肠炎 17 型炎症。

Becalming Type 17 Inflammation in Ulcerative Colitis.

机构信息

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK.

MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, UK.

出版信息

Immunity. 2019 Apr 16;50(4):1029-1031. doi: 10.1016/j.immuni.2019.03.019.

DOI:10.1016/j.immuni.2019.03.019
PMID:30995495
Abstract

Genome-wide association studies in ulcerative colitis point to a role for FcγRIIA, a receptor for IgG. Castro-Dopico et al. (2019) find a profound induction of anti-commensal IgG in the colonic mucosa of UC patients and outline a pathway whereby FcγR activation by IgG triggers IL-1β production, type 17 immunity, and the exacerbation of inflammation.

摘要

全基因组关联研究在溃疡性结肠炎中指出了 FcγRIIA 的作用,FcγRIIA 是 IgG 的受体。Castro-Dopico 等人(2019 年)发现 UC 患者结肠黏膜中存在严重的抗共生 IgG 诱导,并概述了一种途径,即 IgG 激活 FcγR 触发 IL-1β 产生、17 型免疫和炎症加剧。

相似文献

1
Becalming Type 17 Inflammation in Ulcerative Colitis.缓解溃疡性结肠炎 17 型炎症。
Immunity. 2019 Apr 16;50(4):1029-1031. doi: 10.1016/j.immuni.2019.03.019.
2
Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis.抗共生 IgG 驱动溃疡性结肠炎的肠道炎症和 17 型免疫。
Immunity. 2019 Apr 16;50(4):1099-1114.e10. doi: 10.1016/j.immuni.2019.02.006. Epub 2019 Mar 12.
3
Mucosal CXCR4+ IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation.黏膜 CXCR4+ IgG 浆细胞通过 FcγR 介导的 CD14 巨噬细胞活化促进人类溃疡性结肠炎的发病机制。
Gut. 2013 Dec;62(12):1734-44. doi: 10.1136/gutjnl-2012-303063. Epub 2012 Sep 26.
4
Mucosal IgG in inflammatory bowel disease - a question of (sub)class?炎症性肠病中的黏膜 IgG-(亚)类问题?
Gut Microbes. 2020 Nov 9;12(1):1-9. doi: 10.1080/19490976.2019.1651596. Epub 2019 Sep 3.
5
Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling.腺苷 A3 受体的激活通过下调核因子-κB 信号通路抑制溃疡性结肠炎患者结肠黏膜中炎症细胞因子的产生。
J Dig Dis. 2020 Jan;21(1):38-45. doi: 10.1111/1751-2980.12831. Epub 2019 Dec 17.
6
A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.一种新型局部过氧化物酶体增殖物激活受体 γ 激动剂可诱导溃疡性结肠炎黏膜过氧化物酶体增殖物激活受体 γ 活性,并可预防和逆转诱导性结肠炎模型中的炎症。
Inflamm Bowel Dis. 2018 Mar 19;24(4):792-805. doi: 10.1093/ibd/izx079.
7
Treatment of ulcerative colitis with Wu-Mei-Wan by inhibiting intestinal inflammatory response and repairing damaged intestinal mucosa.乌美溴铵治疗溃疡性结肠炎通过抑制肠道炎症反应和修复受损的肠道黏膜。
Phytomedicine. 2022 Oct;105:154362. doi: 10.1016/j.phymed.2022.154362. Epub 2022 Jul 30.
8
Immunoglobulin G (IgG), IgG1, and IgG2 determinations from endoscopic biopsy specimens in control, Crohn's disease, and ulcerative colitis subjects.对对照组、克罗恩病患者和溃疡性结肠炎患者的内镜活检标本进行免疫球蛋白G(IgG)、IgG1和IgG2测定。
Gut. 1992 Apr;33(4):507-12. doi: 10.1136/gut.33.4.507.
9
Related IgA1 and IgG producing cells in blood and diseased mucosa in ulcerative colitis.溃疡性结肠炎患者血液及病变黏膜中产生相关IgA1和IgG的细胞
Gut. 2002 Jul;51(1):44-50. doi: 10.1136/gut.51.1.44.
10
Qingchang Wenzhong Decoction ameliorates intestinal inflammation and intestinal barrier dysfunction in ulcerative colitis via the GC-C signaling pathway.清肠温中汤通过 GC-C 信号通路改善溃疡性结肠炎的肠道炎症和肠屏障功能障碍。
J Ethnopharmacol. 2024 Mar 25;322:117503. doi: 10.1016/j.jep.2023.117503. Epub 2023 Dec 1.

引用本文的文献

1
Inflammatory Bowel Disease: A Comprehensive Analysis of Molecular Bases, Predictive Biomarkers, Diagnostic Methods, and Therapeutic Options.炎症性肠病:分子基础、预测生物标志物、诊断方法和治疗选择的综合分析。
Int J Mol Sci. 2024 Jun 27;25(13):7062. doi: 10.3390/ijms25137062.
2
The potential mechanism of huazhuojiedu decoction in the treatment of ulcerative colitis based on network pharmacology and experimental validation.基于网络药理学和实验验证的化浊解毒方治疗溃疡性结肠炎的潜在机制
Front Pharmacol. 2022 Oct 14;13:1033874. doi: 10.3389/fphar.2022.1033874. eCollection 2022.
3
Inhibition of the activation of γδT17 cells through PPARγ-PTEN/Akt/GSK3β/NFAT pathway contributes to the anti-colitis effect of madecassic acid.
通过 PPARγ-PTEN/Akt/GSK3β/NFAT 通路抑制 γδT17 细胞的激活有助于积雪草酸的抗结肠炎作用。
Cell Death Dis. 2020 Sep 14;11(9):752. doi: 10.1038/s41419-020-02969-x.